CENTRAL D2-DOPAMINE RECEPTOR OCCUPANCY IN RELATION TO ANTIPSYCHOTIC DRUG EFFECTS - A DOUBLE-BLIND PET STUDY OF SCHIZOPHRENIC-PATIENTS

被引:425
作者
NORDSTROM, AL [1 ]
FARDE, L [1 ]
WIESEL, FA [1 ]
FORSLUND, K [1 ]
PAULI, S [1 ]
HALLDIN, C [1 ]
UPPFELDT, G [1 ]
机构
[1] KAROLINSKA INST,DEPT PSYCHIAT & PSYCHOL,S-10401 STOCKHOLM 60,SWEDEN
关键词
PET; D2-DOPAMINE RECEPTORS; NEUROLEPTIC DRUGS; SCHIZOPHRENIA; DRUG EFFECTS (HUMAN) (RACLOPRIDE);
D O I
10.1016/0006-3223(93)90288-O
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The relationship between central D2-dopamine receptor occupancy and antipsychotic drug effects was examined in a double-blind study. Raclopride was the compound used to induce a selective occupancy of the D2-dopamine receptors. In addition, C-11-labeled raclopride was the radioligand used to measure occupancy by positron emission tomography (PET). Seventeen schizophrenic patients were randomly assigned to one of three parallel groups treated for 4 weeks with daily doses of 2, 6, or 12 mg of raclopride. D2-receptor occupancy was determined by PET at steady-state conditions in 13 patients who completed the study. A statistically significant relationship was demonstrated between antipsychotic effect and degree of D2-receptor occupancy (p < 0.05). Patients with extrapyramidal side effects had significantly higher D2-receptor occupancy than those without (p = 0.02). The finding of a relationship between selective occupancy of the D2-dopamine receptors and clinical effects in schizophrenic patients principally provides new support for the dopamine hypothesis of antipsychotic drug action.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 44 条
[1]  
BALDESSARINI RJ, 1988, ARCH GEN PSYCHIAT, V45, P79
[2]   A RATING-SCALE FOR DRUG-INDUCED AKATHISIA [J].
BARNES, TRE .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :672-676
[3]   STRIATAL DOPAMINE RECEPTOR OCCUPANCY DURING AND FOLLOWING WITHDRAWAL FROM NEUROLEPTIC TREATMENT - CORRELATIVE EVALUATION BY POSITRON EMISSION TOMOGRAPHY AND PLASMA PROLACTIN LEVELS [J].
BARON, JC ;
MARTINOT, JL ;
CAMBON, H ;
BOULENGER, JP ;
POIRIER, MF ;
CAILLARD, V ;
BLIN, J ;
HURET, JD ;
LOCH, C ;
MAZIERE, B .
PSYCHOPHARMACOLOGY, 1989, 99 (04) :463-472
[4]   HEAD FIXATION DEVICE FOR REPRODUCIBLE POSITION ALIGNMENT IN TRANSMISSION CT AND POSITRON EMISSION TOMOGRAPHY [J].
BERGSTROM, M ;
BOETHIUS, J ;
ERIKSSON, L ;
GREITZ, T ;
RIBBE, T ;
WIDEN, L .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1981, 5 (01) :136-141
[5]   DETERMINATION OF OBJECT CONTOUR FROM PROJECTIONS FOR ATTENUATION CORRECTION IN CRANIAL POSITRON EMISSION TOMOGRAPHY [J].
BERGSTROM, M ;
LITTON, J ;
ERIKSSON, L ;
BOHM, C ;
BLOMQVIST, G .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1982, 6 (02) :365-372
[6]  
BISHOP MP, 1966, ARCH GEN PSYCHIAT, V14, P497
[7]   INVIVO ASSAY FOR NEUROLEPTIC RECEPTOR-BINDING IN THE STRIATUM - POSITRON TOMOGRAPHY IN HUMANS [J].
CAMBON, H ;
BARON, JC ;
BOULENGER, JP ;
LOCH, C ;
ZARIFIAN, E ;
MAZIERE, B .
BRITISH JOURNAL OF PSYCHIATRY, 1987, 151 :824-830
[8]   ANTIPSYCHOTIC-DRUGS, NEUROTRANSMITTERS, AND SCHIZOPHRENIA [J].
CARLSSON, A .
AMERICAN JOURNAL OF PSYCHIATRY, 1978, 135 (02) :164-173
[9]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[10]   PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY [J].
DAHL, SG .
CLINICAL PHARMACOKINETICS, 1986, 11 (01) :36-61